Trump taps Nicole Saphier for surgeon general after pulling Casey Means nomination

8 hours ago

Eli Lilly shares surge on a beat-and-raise, proving the stock's swoon was a mistake

8 hours ago

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list

8 hours ago

More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says

14 hours ago

Merck beats quarterly estimates on strength of Keytruda, narrows outlook

14 hours ago

Eli Lilly blows past quarterly estimates, hikes outlook

16 hours ago

Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'

2 days ago

Pharma bets on a little-known cholesterol for its next blockbuster heart drugs

2 days ago

Spotify teams up with Peloton to launch global fitness content hub

3 days ago

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

3 days ago

Regeneron weighs overseas price for gene therapy for rare type of hearing loss

3 days ago

FDA fast-tracks psychedelic drug research following Trump executive order

6 days ago

Cramer says look to these 4 stocks to go with your high-flying tech names

7 days ago

Regeneron inks drug pricing deal with Trump, will offer hearing-loss therapy for free

7 days ago

Trump admin moves to reclassify cannabis in shift that could expand research

7 days ago

RFK Jr. says he would support a potential ban on junk food TV ads

8 days ago

Amazon launches GLP-1 weight loss program, promising 'fast, convenient' access

9 days ago

UnitedHealth Group tops quarterly estimates, hikes profit outlook

9 days ago

How Trump's psychedelics executive order could unlock stalled cannabis reform

10 days ago

Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7 billion

10 days ago

After a rare disease left her paralyzed, she's running the Boston Marathon

10 days ago

Naomi Watts' menopause message: 'Why is it so taboo when we are half population'

10 days ago

Trump nominates Erica Schwartz as CDC director

14 days ago

Here's our monthly update on all 31 portfolio stocks, including 3 on the buy list

14 days ago

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves

14 days ago

Novo Nordisk partners with OpenAI as AI drug discovery hopes mount

16 days ago

Revolution Medicines says its pancreatic cancer drug succeeds in late-stage trial

16 days ago

A mom tech entrepreneur building AI advocate for rare-disease families like hers

17 days ago

Trump policies, China's biotech boom are ending Europe's pharma powerhouse era

19 days ago

Former senator shines spotlight on a possible breakthrough for pancreatic cancer

19 days ago

CNBC Cures: A doctor dad on how raising child with Angelman syndrome changed him

20 days ago

Novo Nordisk's Wegovy pill launch draws a new wave of patients into GLP-1s

21 days ago